Annamaria DeSalva

AnnaMaria re-joined H+K as CEO in 2019, having left as Worldwide Director of Healthcare in 2006. AnnaMaria was previously a Senior Advisor to DowDuPont’s CEO, following roles at Pfizer and the U.S. Food and Drug Administration.